Republican health strategist Joel White said the lawsuit from Merck comes as no surprise considering various transparency and input issues raised by drug makers, lawmakers, patient groups and other stakeholders. […]
Click here to download the June Horizon Highlight.
Horizon’s Brett Meeks spoke with Inside Telehealth about recent attempts by the FTC to regulate health data. Federal agencies — like the FTC — attempting to protect sensitive health data […]
Horizon’s research was cited in a recent Wall Street Journal article about the Inflation Reduction Act’s drug pricing negotiations. CBO predicted only a dozen drugs would be lost by 2039, […]
President Biden released his Fiscal Year 2024 Budget on March 9. Highlights from the budget, include: This month’s Horizon Highlight examines the budget process from start to finish.
This month’s Horizon Highlight spotlights upcoming Congressional deadlines and the committees that have jurisdiction. Since states are taking a more active role in healthcare legislation, we have also included a […]
Horizon’s Joel White was interviewed by The New York Times about Sen. Bernie Sanders new role as head of the Senate Health Committee. Joel White, a Republican strategist who specializes […]
Horizon CEO Joel White shared his insights on the impact 2022 had on health policy during “The Year Ahead in Health Policy” webinar sponsored by The Commonwealth Fund. The Benefits […]
Inside Health Policy included Horizon’s and the Council for Affordable Health Coverage’s efforts to increase interest in value-based payment arrangements for high cost drugs. Joel White, president and CEO of […]
This month’s Horizon Highlight spotlights key Congressional Committees and their leadership.*At the time of posting, not all seats had officially been filled.